Equities

ConvaTec Group PLC

CTEC:LSE

ConvaTec Group PLC

Health CareMedical Equipment and Services
  • Price (GBX)257.80
  • Today's Change-17.80 / -6.46%
  • Shares traded21.88m
  • 1 Year change19.35%
  • Beta0.5527
Data delayed at least 20 minutes, as of Apr 26 2024 18:52 BST.
More ▼

Profile data is unavailable for this security.

About the company

Convatec Group Plc is a United Kingdom-based medical products and technologies company. The Company is engaged in the development, manufacture and sale of medical products, services, and technologies. It is focused on solutions for the management of chronic conditions. It markets and sells its solutions and services in four categories, such as Advanced Wound Care, Ostomy Care, Continence and Critical Care, and Infusion Care. Its Advanced Wound Care includes advanced solutions for the management of acute and chronic wounds resulting from ongoing conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. Ostomy Care includes devices, accessories and personalized services for individuals with a stoma. Its Continence and Critical Care includes products and services for people with urinary continence issues, and other devices for critical care. Its Infusion Care includes disposable infusion sets used in insulin pump therapy for people with diabetes.

  • Revenue in GBP (TTM)1.72bn
  • Net income in GBP104.33m
  • Incorporated2016
  • Employees10.13k
More ▼

Peer analysis

CompanyRevenue (TTM)Net income (TTM)Market capEmployeesMarket Cap /
Employees
Embla Medical hf643.82m45.57m1.44bn4.00k1.44bn4.00k
SKAN Group AG280.22m23.04m1.61bn1.39k1.61bn1.39k
Medacta Group SA437.12m40.53m1.93bn1.73k1.93bn1.73k
Elekta AB (publ)1.34bn105.03m2.04bn4.58k2.04bn4.58k
Ambu A/S562.17m27.32m2.98bn4.70k2.98bn4.70k
GN Store Nord A/S2.08bn26.17m3.26bn7.17k3.26bn7.17k
Ypsomed Holding AG445.35m63.41m4.03bn2.20k4.03bn2.20k
Getinge AB2.36bn167.40m4.38bn11.86k4.38bn11.86k
SCHOTT Pharma AG & Co KgaA775.36m135.37m5.12bn4.65k5.12bn4.65k
ConvaTec Group PLC1.72bn104.33m5.29bn10.13k5.29bn10.13k
Amplifon SpA1.93bn132.82m6.11bn14.38k6.11bn14.38k
Carl Zeiss Meditec AG1.79bn236.94m7.68bn4.82k7.68bn4.82k
Data as of Apr 26 2024. Currency figures normalised to ConvaTec Group PLC's reporting currency: UK Pound GBX

Institutional shareholders

30.68%Per cent of shares held by top holders
HolderShares% Held
Black Creek Investment Management, Inc.as of 23 Apr 2024102.41m5.00%
Artisan Partners LPas of 31 Dec 202297.98m4.78%
Capital Research & Management Co. (Global Investors)as of 31 Dec 202297.42m4.75%
Schroder Investment Management Ltd.as of 02 Apr 202457.57m2.81%
The Vanguard Group, Inc.as of 02 Apr 202456.05m2.73%
Massachusetts Financial Services Co.as of 02 Apr 202448.62m2.37%
Royal London Asset Management Ltd.as of 02 Apr 202445.30m2.21%
abrdn Investment Management Ltd.as of 31 Dec 202243.37m2.12%
FIL Investment Advisors (UK) Ltd.as of 02 Apr 202440.58m1.98%
BlackRock Investment Management (UK) Ltd.as of 15 May 202339.63m1.93%
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.